The Xylitol Heart-Risk Study Deserves Attention. Here’s What It Actually Found.

Xylitol has spent a long time in the unusually comfortable category of ingredients: sweet, low in calories, kind to teeth, apparently harmless. You find it in gum, mints, protein bars, powdered sweeteners, “keto” baking mixes, and products sold to people trying to manage diabetes. Then, in 2024, a Cleveland Clinic team published a paper in the European Heart Journal that gave that comfort a sharp edge. In two groups of patients having cardiac evaluation, higher fasting blood levels of xylitol were associated with more heart attacks, strokes, and cardiovascular deaths over the next three years. The same paper also found that xylitol made platelets more reactive in laboratory experiments and after a drink containing xylitol was given to ten healthy volunteers.

That is worth paying attention to. It is also very easy to turn into a worse claim than the study supports. The paper did not show that a piece of xylitol gum causes a heart attack. It did not follow people as they ate particular xylitol-containing foods, and it did not randomize thousands of people to xylitol or a control diet. It found a concerning association in people already carrying a great deal of cardiovascular risk, then paired it with biological experiments that make the association harder to dismiss. Those are different things. Keeping them separate is how we get a useful answer rather than a frightening headline.

The signal came from patients who were already at high risk

The research began with blood samples collected from 1,157 stable patients undergoing elective cardiac assessment. The investigators used metabolomics, a technique that surveys many small molecules in blood at once, and noticed that higher levels of a molecule tentatively identified as xylitol tracked with major adverse cardiovascular events over three years. They then tested that finding in a separate group of 2,149 patients using a more specific measurement method that could distinguish xylitol from similar compounds. The second cohort was not a group of healthy twenty-somethings. Roughly three quarters had a history of cardiovascular disease, about one in five had diabetes, and most were taking aspirin or statins.

In that validation group, people in the highest third of fasting xylitol levels had an adjusted hazard ratio of 1.57 for major adverse cardiovascular events compared with people in the lowest third. That means the higher-xylitol group had a 57% higher relative rate of the study’s combined outcome after the researchers accounted for several conventional risk factors. It does not mean that every person who eats xylitol has a 57% chance of a heart attack or stroke. Relative risk can sound enormous when it is stripped from the population, timeframe, and baseline risk that produced it.

There is another important wrinkle: the body can make small amounts of xylitol on its own. A high fasting blood level may partly reflect dietary exposure, but it may also reflect metabolism, illness, or both. Observational studies are excellent at raising alarms and poor at assigning blame with certainty. People with diabetes, kidney impairment, established vascular disease, or other metabolic stressors may differ in ways that a statistical adjustment cannot completely erase. The researchers were direct about this limitation. Association is where the human-outcomes part of the paper begins, not where the story ends.

Why the platelet experiments changed the conversation

The investigators did not stop at a blood-level association. They exposed human platelets, platelet-rich plasma, and whole blood to xylitol, then measured what happened when those platelets were given normal activation signals. Platelets became easier to activate and showed more features associated with clot formation. In a mouse model of arterial injury, xylitol also shortened the time to blood-vessel blockage. That is the biological case behind the headline: platelets are the cells that plug a cut, but in the wrong place they can help form the clot that turns a narrowed coronary artery into a heart attack or blocks blood flow to the brain.

The small human experiment is the most vivid part of the paper. Ten healthy volunteers drank a beverage containing 30 grams of xylitol. Their blood xylitol concentrations rose dramatically, as expected, and several measures of platelet responsiveness increased afterward. Every volunteer showed an effect on at least one platelet measure. The experiment does not show that any of those people would have a clinical event; it was too small and too short to answer that question. It does show that swallowing a sizable amount can rapidly produce blood concentrations and platelet changes that fit the proposed mechanism.

That combination, an observational link, a plausible mechanism, animal evidence, and a short human exposure experiment, is stronger than a nutrition headline built on a single questionnaire. Still, it is not a large long-term randomized trial of cardiovascular events. The most honest reading is that xylitol now has a credible cardiovascular safety signal, especially for people already at high risk. It has not yet crossed the evidentiary line that would let anyone calculate a safe intake, an unsafe intake, or the risk from an individual product.

A dental product is not the same exposure as a keto dessert

This distinction matters more than it may seem. Xylitol has dental uses because it is not fermented by the cavity-causing bacteria that thrive on sugar. Chewing sugar-free gum can also stimulate saliva, which helps the mouth after eating. Evidence for xylitol itself is mixed. The American Dental Association describes the potential benefit as an adjunct for people at higher risk of cavities and notes that the quality of evidence is low. A 2024 systematic review found that xylitol gum may reduce cavities in children and adolescents with moderate or high baseline caries activity, while results for xylitol candies were far less convincing. Another review of clinical trials concluded that its preventive effect could not be confirmed consistently.

Those findings do not make fluoride toothpaste optional. Brushing twice daily with fluoride toothpaste, cleaning between teeth, and regular dental care remain the durable basics. Those steps have a much firmer place in caries prevention than any single food additive. Xylitol may be useful in particular dental contexts, but it is not a reason to treat a sweetener as a cardiovascular supplement.

The 30-gram drink used in the platelet experiment speaks most directly to dietary uses where xylitol replaces sugar in bulk: a large serving of a low-sugar dessert, a drink, or a recipe sweetened with powdered xylitol. It does not establish that brushing with xylitol toothpaste and spitting it out carries the same exposure or risk. In a 2025 response to critics, the study authors themselves said that “swish and spit” oral-care products would be expected to involve minimal ingestion, while emphasizing that dietary xylitol is a different question. Gum sits somewhere in between. The amount swallowed, how often it is used, and a person’s individual health all matter, and no cardiovascular-outcomes trial has answered those questions.

The right response depends on your baseline risk

For someone with prior heart attack, stroke, peripheral artery disease, diabetes, chronic kidney disease, or a high burden of cardiovascular risk factors, regular high-dose xylitol is an easy thing to reconsider with a clinician or registered dietitian. That does not require panic or a purge of every bathroom drawer. It means looking first at the largest, most repeated exposures: the powdered sweetener used every day, the snack that provides xylitol by the tablespoon, or the low-sugar foods that have quietly become staples. Labels may list xylitol by name or identify it as a sugar alcohol. Ingredients are more useful than a front-of-package wellness claim here.

For people without known cardiovascular disease, the study is still relevant but does not justify assuming that occasional use is dangerous. The original cohorts were enriched for cardiovascular disease, so their results do not translate cleanly to a low-risk population. At the same time, the platelet findings are a reason not to regard frequent, high-dose use as proven safe merely because a product is labelled natural, diabetic-friendly, or low carb. “Natural” describes neither risk nor dose. Hemlock is natural too. So is water, until enough of it is not.

There is a sensible middle ground. Reduce added sugars because there are clear reasons to do so, but do not replace them automatically with large daily quantities of one sweetener. A diet built around minimally processed food makes that easier without turning every ingredient list into a threat assessment. If a sugar substitute is helping you avoid sugar-sweetened drinks or making a diabetes plan workable, the comparison is not between xylitol and a perfect diet. It is between real alternatives, and that conversation should account for your blood pressure, lipids, glucose, medications, dental risk, and cardiovascular history.

The study points to a question preventive care should take seriously

Preventive medicine is often caricatured as an endless hunt for the next bad ingredient. That is not the useful part of it. The useful part is noticing when a common exposure has outpaced its safety evidence, then matching the response to the person in front of you. Xylitol has long been evaluated mainly for calories, blood sugar, dental effects, and gastrointestinal tolerance. The Cleveland Clinic paper asks a different question: what does it do to clotting biology in people most vulnerable to a clot?

We need bigger studies that measure actual intake, include people with different baseline risks, and follow clinical outcomes long enough to distinguish a biomarker from a cause. Until then, the paper should change the tone of the conversation. Xylitol is not established as a harmless all-purpose sugar replacement, particularly when used in large dietary amounts by people with cardiovascular disease. It is also not proven to make a tube of toothpaste dangerous. Those two statements can coexist, and they leave room for a decision that is cautious without becoming theatrical.

If you have had a cardiovascular event, take several medications, or use xylitol frequently as part of a diabetes or weight-management plan, bring the product or ingredient list to your next appointment. A clinician who knows your full risk profile can help decide whether changing it is meaningful and what would work in its place. That is a better standard than fear, and better than blind reassurance.

---

References

1. Witkowski M, Nemet I, Li XS, et al. Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal. 2024;45(27):2439-2452. DOI: 10.1093/eurheartj/ehae244. pubmed.ncbi.nlm.nih.gov/38842092/

2. Valentine GC, Soderling E, Milgrom P. Oral health benefits and safety of xylitol and potential cardiovascular risk: questioning the validity of the model of Witkowski et al. European Heart Journal. 2025;46(27):2705-2706. DOI: 10.1093/eurheartj/ehaf058.

3. Witkowski M, Hazen SL. Xylitol and cardiovascular risks. European Heart Journal. 2025;46(27):2707-2708. DOI: 10.1093/eurheartj/ehaf059. academic.oup.com/eurheartj/article/46/27/2707/8069563

4. American Dental Association. Nutrition and Oral Health. Updated 2023. ada.org/resources/ada-library/oral-health-topics/nutrition-and-oral-health

5. Pienihäkkinen K, Hietala-Lenkkeri A, Arpalahti I, Söderling E. The effect of xylitol chewing gums and candies on caries occurrence in children: a systematic review with special reference to caries level at study baseline. European Archives of Paediatric Dentistry. 2024;25(2):145-160. DOI: 10.1007/s40368-024-00875-w.

6. Ortiz-Sáez B, Aguilella-Traver M, Hernández-Pando C, et al. Is xylitol effective in the prevention of dental caries? A systematic review. Journal of Clinical and Experimental Dentistry. 2024;16(10):e1307-e1315. DOI: 10.4317/jced.62008.

Word count: 1,717